Cognition Therapeutics launching clinical trials for Alzheimer’s drug in Australia 10.18.16 Clinical trials will begin in Melbourne Australia for Cognition Therapeutics’ new Alzheimer’s treatment drug, CT1812. Read more in the Pittsburgh Business Times